Madrid, April 23rd, 2004.- Natraceutical’s Board approved in its meeting yesterday, Thursday April 22nd, the issue of 38,521,165 shares, for a nominal amount of 3,852,116.5 Euros, allowing it to raise 20,031,005.80 Euros. The new shares will have the same rights as all bonds currently in circulation, taking effect from January 1st, 2004, and with an issue price of 0.52 Euros.
Upon the approval of the Prospectus by the CNMV, a 10-day period will be established to enable Natraceutical’s shareholders to subscribe 5 new shares for every 19 old shares in their power the day before this preferential subscription period commences and in which the rights, valued according to yesterday’s closing at 0.075 Euros, will also be listed.
The 20 million Euros which Natraceutical will raise will enable it to strengthen its own resources and deal, in the best conditions possible, with projects which are already included in the prospectus of its floating on the stock market, in addition to other product or business lines in which it’s working.
Natraceutical currently trades 22 functional ingredients, and purified caffeine (it is one of the first world producers of this product) and serves almost 400 clients in more than 50 countries around the world, exporting 90% of its sales to the five continents. During 2003 and 2004 it has applied for five patents for functional ingredients and active principles, all derived from raw, natural materials, especially from the Mediterranean area. It also takes part in Biópolis, a biotechnological company directed at custom-made R+D activities for the food and pharmaceutical sectors, which was launched in April 2003 with the Consejo Superior de Investigaciones Científicas (Board of Scientific Research-CSIC), CAPSA and the Capital-Risk entity, TALDE. In 2003, Natraceutical achieved net profits of 2 million Euros, thus multiplying six-fold its previous year’s profits.
The world market for functional ingredients and nutraceuticals, whose main markets are the United States and Japan, rose to more than 34,000 million USD in 2002, reflecting a growth of 9.2% in relation to the previous year.
Riva y García, which took part in the stock’s launch on the Stock- Exchange, will be the managing and placing entity, and agent.